Dr. Patrick M. Boland
Claim this profileRutgers Cancer Institute of New Jersey
Area of expertise
Colon Cancer
Patrick M. Boland has run 5 trials for Colon Cancer. Some of their research focus areas include:
Rectal Cancer
Patrick M. Boland has run 4 trials for Rectal Cancer. Some of their research focus areas include:
Affiliated Hospitals
Rutgers Cancer Institute Of New Jersey
Saint Barnabas Medical Center
Clinical Trials Patrick M. Boland is currently running
sFOLFOXIRI
for Gastroesophageal Cancer
The primary objective is to determine the clinical efficacy of treatment regimen in terms of objective response rate (ORR). The secondary objectives is to determine the clinical efficacy of the study treatment in terms of progression free survival (PFS) and overall survival (OS). Additionally, to characterize the safety and toxicity profile of the study treatment as measured by the adverse event rates.
Recruiting
1 award
Phase 2
17 criteria
Targeted Therapy
for Solid Tumors
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment directed by genetic testing. Patients with solid tumors that have spread to nearby tissue or lymph nodes (locally advanced) or have spread to other places in the body (advanced) and have progressed on at least one line of standard systemic therapy or have no standard treatment that has been shown to prolong overall survival may be candidates for these trials. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with some genetic changes or abnormalities (mutations) may benefit from treatment that targets that particular genetic mutation. ComboMATCH is designed to match patients to a treatment that may work to control their tumor and may help doctors plan better treatment for patients with locally advanced or advanced solid tumors.
Recruiting
1 award
Phase 2
17 criteria
More about Patrick M. Boland
Clinical Trial Related
6 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Patrick M. Boland has experience with
- Capecitabine
- Panitumumab
- Oxaliplatin
- Fluorouracil
- Leucovorin
- Sotorasib
Breakdown of trials Patrick M. Boland has run
Colon Cancer
Rectal Cancer
Colorectal Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Patrick M. Boland specialize in?
Patrick M. Boland focuses on Colon Cancer and Rectal Cancer. In particular, much of their work with Colon Cancer has involved Stage IV patients, or patients who are KRAS negative.
Is Patrick M. Boland currently recruiting for clinical trials?
Yes, Patrick M. Boland is currently recruiting for 3 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Patrick M. Boland has studied deeply?
Yes, Patrick M. Boland has studied treatments such as Capecitabine, Panitumumab, Oxaliplatin.
What is the best way to schedule an appointment with Patrick M. Boland?
Apply for one of the trials that Patrick M. Boland is conducting.
What is the office address of Patrick M. Boland?
The office of Patrick M. Boland is located at: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903 United States. This is the address for their practice at the Rutgers Cancer Institute of New Jersey.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.